Skip to main content

Gloria Pascual: research led by Joan Massagué “paves the way for the development of new drugs”




Press & Communications Section Head
Tel.+34 93 40 37255

EFE Salud’s radio programme El Bisturí has interviewed Gloria Pascual, researcher with IRB Barcelona’s Stem Cells and Cancer Laboratory at the Institute for Research in Biomedicine (IRB Barcelona), in relation to research by Joan Massagué, Director of the Sloan Kettering Institute, co-founder of IRB Barcelona and current Chair of its External Advisory Board. The study in question describes the origin of metastasis, a process by which cells leave the primary tumour, invade vital organs and seed a new tumour. Metastasis is responsible for 90% of cancer deaths.

The main goal of the research into this field is to discover new therapeutic targets specifically against metastatic cells. The study headed by Massagué identifies the protein that mediates metastasis. “This paves the way for the development of new drugs that can be used for certain types of tumour, and especially for those that express high levels of this protein,” says Pascual.

link to: El Bisturí (minuto 01:00- 11:00)


About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).